Formulation of dacarbazine-loaded cubosomes-part I: Influence of formulation variables

AAPS PharmSciTech

Volumn 10, Issue 3, 2009, Pages 1032-1039

  Bei, Di ^a   Marszalek, Jacob ^a   Youan, Bi Botti C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Box Behnken design; Cubosomes; Dacarbazine; Formulation variables

Indexed keywords

CUBOSOME; DACARBAZINE; GLYCEROL OLEATE; NANOCARRIER; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; DRUG FORMULATION; ENCAPSULATION; MATHEMATICAL ANALYSIS; MULTIPLE REGRESSION; PARTICLE SIZE; PROCESS OPTIMIZATION; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, CUTANEOUS; ALGORITHMS; ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; DACARBAZINE; DRUG COMPOUNDING; DRUG STABILITY; MICROSCOPY, ELECTRON, TRANSMISSION; MODELS, STATISTICAL; NANOPARTICLES; PARTICLE SIZE;

EID: 70449522988     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9293-3     Document Type: Article

References (25)

1. K Spieth R Kaufmann R Dummer C Garbe JC Becker A Hauschild, et al. 2008 Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG) Ann Oncol 19 4 801 806 18178958 10.1093/annonc/mdm565 1:STN:280:DC%2BD1c3gsVyhsA%3D%3D
2. D Schadendorf S Ugurel B Schuler-Thurner FO Nestle A Enk EB Brocker, et al. 2006 Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG Ann Oncol 17 4 563 570 16418308 10.1093/annonc/mdj138 1:STN:280: DC%2BD287mslSltA%3D%3D
3. MB Lens TG Eisen 2003 Systemic chemotherapy in the treatment of malignant melanoma Expert Opin Pharmacother 4 12 2205 2211 14640919 10.1517/14656566.4. 12.2205 1:CAS:528:DC%2BD3sXptlemur8%3D (Pubitemid 37541234)
4. K Larsson 1983 Two cubic phases in monoolein-water system Nature 304 664 10.1038/304664c0
5. T Nylander C Mattisson V Razumas Y Meizis B Hakansson 1996 A study of entrapped enzyme stability and substrate diffusion in a monoglyceride-based cubic liquid crystalline phase Colloid Surf A: Physicochem Eng Aspects 114 311 320 10.1016/0927-7757(96)03563-7 1:CAS:528:DyaK28Xks1eht7s%3D (Pubitemid 26256961)
6. J Barauskas M Johnsson F Joabsson F Tiberg 2005 Cubic phase nanoparticles (cubosome): principles for controlling size, structure, and stability Langmuir 21 6 2569 2577 15752054 10.1021/la047590p 1:CAS:528:DC%2BD2MXhtlCns7o%3D (Pubitemid 40421910)
7. J Barauskas M Johnsson F Tiberg 2005 Self-assembled lipid superstructures: beyond vesicles and liposomes Nano Lett 5 8 1615 1619 16089498 10.1021/nl050678i 1:CAS:528:DC%2BD2MXjslers7Y%3D (Pubitemid 41251697)
8. S Engstrom B Ericsson T Landh 1996 A cubosome formulation for intravenous administration of somatostatin Proc Int Symp Control Rel Bioact Mater 23 2
9. H Chung J Kim JY Um IC Kwon SY Jeong 2002 Self-assembled "nanocubicle" as a carrier for peroral insulin delivery Diabetologia 45 3 448 451 11914752 10.1007/s00125-001-0751-z 1:CAS:528:DC%2BD38XitVeisro%3D (Pubitemid 34267369)
10. E Esposito R Cortesi M Drechsler L Paccamiccio P Mariani C Contado, et al. 2005 Cubosome dispersions as delivery systems for percutaneous administration of indomethacin Pharm Res 22 12 2163 2173 16267633 10.1007/s11095-005-8176-x 1:CAS:528:DC%2BD2MXhtlemtbbO (Pubitemid 41821596)
11. BJ Boyd 2003 Characterisation of drug release from cubosomes using the pressure ultrafiltration method Int J Pharm 260 2 239 247 12842343 10.1016/S0378-5173(03)00262-X 1:CAS:528:DC%2BD3sXkvFektL8%3D (Pubitemid 36773921)
12. JC Shah Y Sadhale DM Chilukuri 2001 Cubic phase gels as drug delivery systems Adv Drug Deliv Rev 47 2-3 229 250 11311994 10.1016/S0169-409X(01)00108-9 1:CAS:528:DC%2BD3MXislGls7c%3D (Pubitemid 32324116)
13. CK Drummond C Fong 1999 Surfactant self-assembly objects as novel drug delivery vehicles Curr Opin Colloid Interf Sci 4 8
14. G Garg S Saraf S Saraf 2007 Cubosomes: an overview Biol Pharm Bull 30 2 350 353 17268078 10.1248/bpb.30.350 1:CAS:528:DC%2BD2sXkvVSms7s%3D (Pubitemid 46255382)
15. AB Solanki JR Parikh RH Parikh 2007 Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design AAPS PharmSciTech 8 4 E86 18181547 10.1208/pt0804086
16. A Maghsoudi SA Shojaosadati E Vasheghani Farahani 2008 5-Fluorouracil-loaded BSA nanoparticles: formulation optimization and in vitro release study AAPS PharmSciTech 9 4 1092 1096 18850275 10.1208/s12249-008-9146-5
17. N Nattapulwat N Purkkao O Suwithayapan 2009 Preparation and application of carboxymethyl yam (Dioscorea esculenta) starch AAPS PharmSciTech 10 193 198 19238555 10.1208/s12249-009-9194-5
18. GEP Box DW Behnken 1960 Some new three level designs for the study of quantitative variables Technometrics 2 455 476 10.2307/1266454
19. SL Ferreira RE Bruns EG da Silva WN Dos Santos CM Quintella JM David, et al. 2007 Statistical designs and response surface techniques for the optimization of chromatographic systems J Chromatogr A 1158 1-2 2 14 17416377 10.1016/j.chroma.2007.03.051 1:CAS:528:DC%2BD2sXnsFylsL8%3D (Pubitemid 47021146)
20. Hackley VA, Ferraris CF, editors. The use of nomenclature in dispersion science and technology. NIST Recommended Practice Guide: National Institute of Standards 2001.
21. E Esposito N Eblovi S Rasi M Drechsler GM Di Gregorio E Menegatti, et al. 2003 Lipid-based supramolecular systems for topical application: a preformulatory study AAPS PharmSci 5 4 E30 15198518 10.1208/ps050430 (Pubitemid 38097475)
22. A Yaghmur P Laggner S Zhang M Rappolt 2007 Tuning curvature and stability of monoolein bilayers by designer lipid-like peptide surfactants PLoS ONE 2 5 e479 17534429 10.1371/journal.pone.0000479
23. SM Moghimi AC Hunter JC Murray 2001 Long-circulating and target-specific nanoparticles: theory to practice Pharmacol Rev 53 2 283 318 11356986 1:CAS:528:DC%2BD3MXkt1Gnurc%3D
24. G Derringer R Suich 1980 Simultaneous optimization of several responses variables J Qual Technol 12 214 219
25. GEP Box DR Cox 1964 An analysis of transformations J Royal Stat Soc, B. 26 211 243